ARTICLE | Company News
FDA approves Cuvposa for drooling
July 29, 2010 12:30 AM UTC
FDA approved an NDA from Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507) for Cuvposa glycopyrrolate to treat chronic severe drooling caused by neurologic disorders in children ages three to 16 years. Shi...